COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.

Clift, Ashley Kieran; Coupland, Carol A C; Keogh, Ruth H; Hemingway, Harry; Hippisley-Cox, Julia

Clift, Ashley Kieran; Coupland, Carol A C; Keogh, Ruth H; Hemingway, Harry; Hippisley-Cox, Julia.

Clift AK; University of Oxford, Oxford, United Kingdom.
Coupland CAC; University of Nottingham, Nottingham, United Kingdom.
Keogh RH; London School of Hygiene & Tropical Medicine, London, United Kingdom.
Hemingway H; University College London, Health Data Research UK, and National Institute for Health Research Biomedical Research Centre, London, United Kingdom.
Hippisley-Cox J; University of Oxford, Oxford, United Kingdom.

Ann Intern Med ; 174(4): 572-576, 2021 04.

Article in English | MEDLINE | ID: covidwho-1201315

Subject(s)

COVID-19/mortality; Down Syndrome/complications; Adult; Aged; Female; Humans; Male; Middle Aged; Risk Factors; SARS-CoV-2; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Down Syndrome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article Affiliation country: M20-4986

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google